Learn about our healthcare areas

Explore medicine and therapy products
Explore MedTech products

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

Search Results

No Results

    Recently Viewed

      Listening...

      Sorry, I don't understand. Please try again
      1. Home/
      2. Media Center/
      3. Press releases /
      4. Innovative Medicine

      Innovative Medicine

      Innovative Medicine
      February 6, 2014

      Johnson & Johnson Ranked as Pharma Industry’s Most Productive Innovator for the Second Consecutive Year

      Learn more
      Innovative Medicine
      January 9, 2014

      Johnson & Johnson Innovation Expands Global Incubator Presence to Israel and Announces Multiple, Diverse, Early-Stage Collaborations with Academia and Biotech

      Learn more
      Innovative Medicine
      January 8, 2014

      Janssen Pharmaceutical Companies of Johnson & Johnson Submit Citizen Petition to the U.S. FDA Regarding Naming of Biosimilars

      Ask Agency to require that biosimilars bear distinguishable names to enhance patient safety
      Learn more
      Innovative Medicine
      January 7, 2014

      Independent Data Monitoring Committee Recommends Early Stopping of Phase 3 Study of Ibrutinib in Relapsed/Refractory CLL/SLL Patients Based on a Planned Interim Analysis

      Learn more
      Innovative Medicine
      December 12, 2013

      FDA Issues Complete Response Letter for Canagliflozin/Metformin Fixed-Dose Combination Therapy for Type 2 Diabetes

      Learn more
      Innovative Medicine
      December 9, 2013

      Janssen, the Pharmaceutical Companies of Johnson & Johnson, Announces First-of-its-Kind Drug Donation Program for HIV Treatment-Experienced Children

      Sub-Saharan African Ministries of Health Invited to Submit Expression of Interest to Participate in New EffortDonation Program to be Part of Broader Initiative to Raise Awareness and Action
      Learn more
      Innovative Medicine
      December 9, 2013

      Ibrutinib Data Published in The Lancet Oncology Suggest a Positive Effect in Previously Untreated Chronic Lymphocytic Leukemia Patients Over Age 65

      Encouraging Data from a Phase 1b/2, Open-label, Multicenter Study
      Learn more
      Innovative Medicine
      December 9, 2013

      New VELCADE® Data Highlight Treatment’s Versatility And Its Continued Role As A Backbone Of Multiple Myeloma Therapy

      Studies affirm benefits of VELCADE (bortezomib) therapy regarding survival, disease progression, safety and quality of life in multiple myeloma, in both monotherapy and combination therapy
      Learn more
      Innovative Medicine
      December 5, 2013

      Janssen Pharmaceutica NV Extends Commitment to Global Mental Health Scholarships as Part of Its Healthy Minds Programme

      Funding to British schools continues meaningful aid for future leaders in mental health research, policy and practice
      Learn more
      Load more